The CAR-T therapies market is characterized by a h..

Nouvel article créé

2 années depuis - Traduire

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, and is projected to be worth around USD 14 Billion in 2030, claims Roots Analysis | #rootsanalysis #pharma #health

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, and is projected to be worth a

Roots Analysis has announced the addition of “CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antige